A Developing Crisis
The Philadelphia Eagles are navigating a challenging middle portion of the 2026 regular season following the news that star quarterback Jalen Hurts has been placed on injured reserve. The situation began after Hurts sustained a calf injury during the team's October 4 loss to the Los Angeles Rams. While initially treated as a superficial issue, the medical outlook shifted dramatically after further testing revealed the presence of blood clots.
Medical Complications
Following the initial calf injury, Hurts sought treatment on October 8. Despite being cleared to play in the team's subsequent game against the Jacksonville Jaguars, follow-up imaging performed after the team's return from London revealed that the condition had worsened. Reports indicate that the quarterback is now dealing with multiple blood clots in his lungs, necessitating a treatment plan involving blood thinners that is expected to keep him sidelined for at least three months.
Impact on the Eagles
The loss of their starting signal-caller is a significant blow to the Eagles' campaign. With Hurts expected to miss the remainder of the season, the team has turned to Tanner McKee to lead the offense. The transition marks a difficult adjustment for the coaching staff and the roster as they attempt to maintain their competitive standing in the NFC without their primary leader under center.
League-Wide Perspective
The severity of the diagnosis has sent shockwaves through the NFL, highlighting the unpredictable nature of player health. As the Eagles and the medical community prioritize Hurts' long-term recovery and safety, the organization remains focused on managing the immediate void left by his absence. The team's decision to place him on injured reserve underscores the seriousness of the medical findings and the uncertainty surrounding his return to professional football.
